These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21504070)

  • 1. The molecular mechanisms of glucocorticoids-mediated neutrophil survival.
    Saffar AS; Ashdown H; Gounni AS
    Curr Drug Targets; 2011 Apr; 12(4):556-62. PubMed ID: 21504070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NETopathic Inflammation in Chronic Obstructive Pulmonary Disease and Severe Asthma.
    Uddin M; Watz H; Malmgren A; Pedersen F
    Front Immunol; 2019; 10():47. PubMed ID: 30804927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel approaches to the management of noneosinophilic asthma.
    Thomson NC
    Ther Adv Respir Dis; 2016 Jun; 10(3):211-34. PubMed ID: 26929306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR2 mediates NADPH oxidase-independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation.
    Marcos V; Zhou Z; Yildirim AO; Bohla A; Hector A; Vitkov L; Wiedenbauer EM; Krautgartner WD; Stoiber W; Belohradsky BH; Rieber N; Kormann M; Koller B; Roscher A; Roos D; Griese M; Eickelberg O; Döring G; Mall MA; Hartl D
    Nat Med; 2010 Sep; 16(9):1018-23. PubMed ID: 20818377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting neutrophils using novel drug delivery systems in chronic respiratory diseases.
    Chellappan DK; Yee LW; Xuan KY; Kunalan K; Rou LC; Jean LS; Ying LY; Wie LX; Chellian J; Mehta M; Satija S; Singh SK; Gulati M; Dureja H; Da Silva MW; Tambuwala MM; Gupta G; Paudel KR; Wadhwa R; Hansbro PM; Dua K
    Drug Dev Res; 2020 Jun; 81(4):419-436. PubMed ID: 32048757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil targeted nano-drug delivery system for chronic obstructive lung diseases.
    Vij N; Min T; Bodas M; Gorde A; Roy I
    Nanomedicine; 2016 Nov; 12(8):2415-2427. PubMed ID: 27381067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta2-agonists potentiate corticosteroid-induced neutrophil survival.
    Perttunen H; Moilanen E; Zhang X; Barnes PJ; Kankaanranta H
    COPD; 2008 Jun; 5(3):163-9. PubMed ID: 18568840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR1 and CXCR2 Inhibition by Ladarixin Improves Neutrophil-Dependent Airway Inflammation in Mice.
    Mattos MS; Ferrero MR; Kraemer L; Lopes GAO; Reis DC; Cassali GD; Oliveira FMS; Brandolini L; Allegretti M; Garcia CC; Martins MA; Teixeira MM; Russo RC
    Front Immunol; 2020; 11():566953. PubMed ID: 33123138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting defective pulmonary innate immunity - A new therapeutic option?
    Belchamber KBR; Donnelly LE
    Pharmacol Ther; 2020 May; 209():107500. PubMed ID: 32061706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting IL-17A/glucocorticoid synergy to CSF3 expression in neutrophilic airway diseases.
    Ouyang S; Liu C; Xiao J; Chen X; Lui AC; Li X
    JCI Insight; 2020 Feb; 5(3):. PubMed ID: 32051346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
    Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
    Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting neutrophils in asthma: A therapeutic opportunity?
    De Volder J; Vereecke L; Joos G; Maes T
    Biochem Pharmacol; 2020 Dec; 182():114292. PubMed ID: 33080186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the role of neutrophils in chronic inflammatory airway disease.
    Jasper AE; McIver WJ; Sapey E; Walton GM
    F1000Res; 2019; 8():. PubMed ID: 31069060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis.
    Simpson JL; Phipps S; Gibson PG
    Pharmacol Ther; 2009 Oct; 124(1):86-95. PubMed ID: 19555716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Interleukin-17 Induced Activation and Increased Survival of Equine Neutrophils Is Insensitive to Glucocorticoids.
    Murcia RY; Vargas A; Lavoie JP
    PLoS One; 2016; 11(5):e0154755. PubMed ID: 27138006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of molecular pathways associated with blood neutrophil corticosteroid insensitivity in equine asthma.
    Pourali Dogaheh S; Boivin R; Lavoie JP
    Vet Immunol Immunopathol; 2021 Jul; 237():110265. PubMed ID: 33989854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil extracellular traps are downregulated by glucocorticosteroids in lungs in an equine model of asthma.
    Vargas A; Boivin R; Cano P; Murcia Y; Bazin I; Lavoie JP
    Respir Res; 2017 Dec; 18(1):207. PubMed ID: 29233147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montelukast versus Dexamethasone Treatment in a Guinea Pig Model of Chronic Pulmonary Neutrophilic Inflammation.
    Abdel Kawy HS
    COPD; 2016 Aug; 13(4):455-63. PubMed ID: 26751767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired anti-inflammatory action of glucocorticoid in neutrophil from patients with steroid-resistant asthma.
    Wang M; Gao P; Wu X; Chen Y; Feng Y; Yang Q; Xu Y; Zhao J; Xie J
    Respir Res; 2016 Nov; 17(1):153. PubMed ID: 27852250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2 inhibitors reduce steroid-insensitive airway inflammation.
    Tian BP; Xia LX; Bao ZQ; Zhang H; Xu ZW; Mao YY; Cao C; Che LQ; Liu JK; Li W; Chen ZH; Ying S; Shen HH
    J Allergy Clin Immunol; 2017 Aug; 140(2):418-430. PubMed ID: 28043871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.